Literature DB >> 17617059

Analysis of the contribution of the globin and reductase domains to the ligand-binding properties of bacterial haemoglobins.

Judith Farrés1, Susanna Burckhardt-Herold, Jan Scherrer, Alexander D Frey, Pauli T Kallio.   

Abstract

Bacterial Hbs (haemoglobins), like VHb (Vitreoscilla sp. Hb), and flavoHbs (flavohaemoglobins), such as FHP (Ralstonia eutropha flavoHb), have different autoxidation and ligand-binding rates. To determine the influence of each domain of flavoHbs on ligand binding, we have studied the kinetic ligand-binding properties of oxygen, carbon monoxide and nitric oxide to the chimaeric proteins, FHPg (truncated form of FHP comprising the globin domain alone) and VHb-Red (fusion protein between VHb and the C-terminal reductase domain of FHP) and compared them with those of their natural counterparts, FHP and VHb. Moreover, we also analysed polarity and solvent accessibility to the haem pocket of these proteins. The rate constants for the engineered proteins, VHb-Red and FHPg, do not differ significantly from those of their natural counterparts, VHb and FHP respectively. Our results suggest that the globin domain structure controls the reactivity towards oxygen, carbon monoxide and nitric oxide. The presence or absence of a reductase domain does not affect the affinity to these ligands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617059      PMCID: PMC2267399          DOI: 10.1042/BJ20070668

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design.

Authors:  J Liang; H Edelsbrunner; C Woodward
Journal:  Protein Sci       Date:  1998-09       Impact factor: 6.725

2.  Expression of Alcaligenes eutrophus flavohemoprotein and engineered Vitreoscilla hemoglobin-reductase fusion protein for improved hypoxic growth of Escherichia coli.

Authors:  A D Frey; J E Bailey; P T Kallio
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

3.  Controlling ligand binding in myoglobin by mutagenesis.

Authors:  Federica Draghi; Adriana Erica Miele; Carlo Travaglini-Allocatelli; Beatrice Vallone; Maurizio Brunori; Quentin H Gibson; John S Olson
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

4.  A new sensitive assay reveals that hemoglobin is oxidatively modified in vivo.

Authors:  Niels B J Vollaard; Brandon J Reeder; Jerry P Shearman; Patrick Menu; Michael T Wilson; Chris E Cooper
Journal:  Free Radic Biol Med       Date:  2005-08-10       Impact factor: 7.376

5.  Interaction of Vitreoscilla hemoglobin with membrane lipids.

Authors:  Andrea C Rinaldi; Alessandra Bonamore; Alberto Macone; Alberto Boffi; Argante Bozzi; Antonio Di Giulio
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

6.  Anticooperative ligand binding properties of recombinant ferric Vitreoscilla homodimeric hemoglobin: a thermodynamic, kinetic and X-ray crystallographic study.

Authors:  M Bolognesi; A Boffi; M Coletta; A Mozzarelli; A Pesce; C Tarricone; P Ascenzi
Journal:  J Mol Biol       Date:  1999-08-20       Impact factor: 5.469

7.  Improved cell growth in tobacco suspension cultures expressing Vitreoscilla hemoglobin.

Authors:  Judith Farrés; Pauli T Kallio
Journal:  Biotechnol Prog       Date:  2002 Mar-Apr

8.  A ubiquitously expressed human hexacoordinate hemoglobin.

Authors:  James T Trent; Mark S Hargrove
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

9.  Nitric oxide dioxygenase: an enzymic function for flavohemoglobin.

Authors:  P R Gardner; A M Gardner; L A Martin; A L Salzman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Interaction with membrane lipids and heme ligand binding properties of Escherichia coli flavohemoglobin.

Authors:  Alessandra Bonamore; Anna Farina; Maurizio Gattoni; M Eugenia Schininà; Andrea Bellelli; Alberto Boffi
Journal:  Biochemistry       Date:  2003-05-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.